HR
IDXX icon

Howe & Rusling’s Idexx Laboratories IDXX Stock Holding History

Howe & Rusling’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.52M Buy
9,815
+172
+2% +$110K 0.36% 75
2025
Q4 		$6.52M Buy
9,643
+185
+2% +$126K 0.43% 62
2025
Q3 		$6.04M Buy
9,458
+1,364
+17% +$828K 0.41% 67
2025
Q2 		$4.34M Buy
8,094
+401
+5% +$192K 0.32% 80
2025
Q1 		$3.23M Buy
7,693
+762
+11% +$331K 0.27% 81
2024
Q4 		$2.87M Buy
+6,931
New +$3.04M 0.25% 83
2021
Q2 		– Sell
-3
Closed -$1K – 987
2021
Q1 		$1K Buy
3
+2
+200% +$1K ﹤0.01% 890
2020
Q4 		$0 Buy
+1
New +$447 ﹤0.01% 966
2020
Q3 		– Sell
-21
Closed -$7K – 836
2020
Q2 		$7K Buy
21
+9
+75% +$2.61K ﹤0.01% 485
2020
Q1 		$3K Buy
+12
New +$3.13K ﹤0.01% 571
2015
Q4 		– Sell
-20
Closed -$1K – 1027
2015
Q3 		$1K Hold
20
– – ﹤0.01% 918
2015
Q2 		$1K Hold
20
– – ﹤0.01% 957
2015
Q1 		$2K Hold
20
– – ﹤0.01% 769
2014
Q4 		$1K Hold
20
– – ﹤0.01% 850
2014
Q3 		$1K Hold
20
– – ﹤0.01% 832
2014
Q2 		$1K Hold
20
– – ﹤0.01% 760
2014
Q1 		$1K Buy
+20
New +$1.19K ﹤0.01% 808

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Howe & Rusling's IDXX Position: Q1 2026 in Review

Howe & Rusling increased its Idexx Laboratories (IDXX) stake by 1.8% in Q1 2026, buying an estimated $110K and bringing the position to 9,815 shares worth $5.52M. The position accounts for 0.36% of the portfolio, ranked #75.

Howe & Rusling first reported a position in IDXX in Q1 2014 and has held it in 17 quarters since. The position peaked at $6.52M in Q4 2025. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Howe & Rusling held 9,815 shares of Idexx Laboratories worth $5.52M as of Q1 2026.
  • Howe & Rusling bought 172 Idexx Laboratories shares in Q1 2026, an estimated $110K.
  • Idexx Laboratories made up 0.36% of Howe & Rusling's portfolio in Q1 2026, its #75 holding.
  • Howe & Rusling first reported a position in Idexx Laboratories in Q1 2014 and has held it in 17 quarters since.
  • Howe & Rusling's Idexx Laboratories position peaked at $6.52M in Q4 2025.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Howe & Rusling's 13F filing for Q1 2026, filed 28 Apr 2026.